New model combines scans and genes to predict stomach cancer survival

NCT ID NCT07190040

Completed Knowledge-focused Sponsor: Chang-Ming Huang, Prof. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at 179 patients with advanced stomach cancer who had chemotherapy and surgery. Researchers used CT scans and genetic data from tumors to build a model that predicts how long patients might stay cancer-free. The goal was to improve survival predictions, not to test a new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this approach could help doctors more accurately predict which gastric cancer patients are likely to stay cancer-free after treatment, guiding personalized follow-up care.
What could go wrong: This is a small, single-center retrospective study, not a clinical trial testing a new treatment. The model needs validation in larger, diverse groups before it can be used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER (GC)

Contacts and locations

Locations

Fujian Medical University

Fuzhou, Fujian, 350001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.